Patient Rating:

No Rating Available?

Kathryn A. Morton, M.D.

Patient Rating:

No Rating Available?

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 581-2370 University Hospital
Radiology
50 N Medical Dr
Salt Lake City, UT 84132
Map

Bio

Kathryn Morton, MD, is a professor in the Department of Radiology at the University of Utah School of Medicine. Morton received her medical degree from the University of Utah, followed by an internship in Pediatrics at the University of North Carolina at Chapel Hill and residencies in Radiology and Nuclear Medicine at the University of Utah.

Board Certification and Academic Information

Academic Departments Radiology - Professor
Academic Divisions Clinical Radiology
Board Certification American Board of Nuclear Medicine (Nuc Med)
American Board of Radiology (Diagnostic Radiology)
National Board of Medical Examiners
Cancer Center Programs Experimental Therapeutics

Academic Profile

Research Interests

  • Tumor Specific PET Probes
  • Positron Emission Tomography (PET)
  • PET-Based Tumor Imaging

Board Certification and Academic Information

Academic Departments Radiology - Professor
Academic Divisions Clinical Radiology
Board Certification American Board of Nuclear Medicine (Nuc Med)
American Board of Radiology (Diagnostic Radiology)
National Board of Medical Examiners
Cancer Center Programs Experimental Therapeutics

Academic Office Locations

Academic Office Phone Number Academic Office Address
School of Medicine
Radiology
30 N Medical Dr
Salt Lake City, UT 84132

Academic Bio

Kathryn Morton, MD, is a professor in the Department of Radiology at the University of Utah School of Medicine. She is an investigator at the Huntsman Cancer Institute and a member of the Experimental Therapeutics program. Her research interests include PET-based tumor imaging and tumor-specific PET probes.

Dr. Morton’s work has explored the use of PET/CT imaging to screen at-risk patients (unprovoked venous thromboembolism) for early or hidden cancers. She has also examined the use of PET/CT as an improved protocol for staging head and neck cancer patients, and has worked to improve the use of PET for radiologic diagnosis of brain cancer. Dr. Morton’s research has also included the development and use of new neuroimaging modalities and probes for the study of neurodegenerative diseases, and she has worked on the use of PET for early diagnosis of acute respiratory distress syndrome and for evaluation of deep vein thrombosis.

Morton received her medical degree from the University of Utah, followed by an internship in Pediatrics at the University of North Carolina at Chapel Hill and residencies in Radiology and Nuclear Medicine at the University of Utah.

Education

Education History

Type School Degree
Residency University of Utah School of Medicine
Diagnostic Radiology
Resident
Residency University of Utah School of Medicine
Nuclear Medicine
Resident
Internship University of North Carolina
Pediatrics
Intern
Research Fellow University of Utah
Molecular Biology
Research Fellow
Professional Medical University of Utah
Medicine
M.D.
Research Fellow University of Utah
Biochemistry
Research Fellow
Undergraduate University of Utah
Biology
B.S.

Publications

Selected Provider Publications

Journal Article

  1. Duff K, Foster NL, Dennett K, Hammers DB, Zollinger LV, Christian PE, Butterfield RI, Beardmore BE, Wang AY, Morton KA, Hoffman JM (2013). Amyloid deposition and cognition in older adults: the effects of premorbid intellect. Arch Clin Neuropsychol, 28(7), 665-71.
  2. Rondina MT, Wanner N, Pendleton RC, Kraiss LW, Vinik R, Zimmerman GA, Heilbrun M, Hoffman JM, Morton KA (2012). A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism. Thromb Res, 129(1), 22-7.
  3. Enslow MS, Zollinger LV, Morton KA, Butterfield RI, Kadrmas DJ, Christian PE, Boucher KM, Heilbrun ME, Jensen RL, Hoffman JM (2012). Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med, 37(9), 854-61.
  4. Rondina MT, Lam UT, Pendleton RC, Kraiss LW, Wanner N, Zimmerman GA, Hoffman JM, Hanrahan C, Boucher K, Christian PE, Butterfield RI, Morton KA (2012). (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis. Clin Nucl Med, 37(12), 1139-45.
  5. Becker JS, Matusch A, Palm C, Salber D, Morton KA, Becker JS (2010). Bioimaging of metals in brain tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and metallomics. Metallomics, 2(2), 104-11.
  6. Wang LM, Becker JS, Wu Q, Oliveira MF, Bozza FA, Schwager AL, Hoffman JM, Morton KA (2010). Bioimaging of copper alterations in the aging mouse brain by autoradiography, laser ablation inductively coupled plasma mass spectrometry and immunohistochemistry. Metallomics, 2(5), 348-53.
  7. Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA (2009). Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med, 50(8), 1205-13.
  8. Rodrigues RS, Miller, PR, Bozza FA, Marchiori E, Zimmerman GA, Hoffman JA, Morton KA (2008). FDG-PET in Patients at Risk for Acute Respiratory Distress Syndrome. A Premliminary Report. Intensive Care Medicine.

Review

  1. Stubbs E, Kraas J, Morton KA, Clark PB (2007). Brain abnormalities detected on whole-body 18F-FDG PET in cancer patients: spectrum of findings. [Review]. AJR Am J Roentgenol, 188(3), 866-73.

Other

  1. Rodrigues RS, Miller PR, Bozza FA, Marchiori E, Zimmerman GA, Hoffman JM, Morton KA (2008). FDG-PET in patients at risk for acute respiratory distress syndrome: a preliminary report. Intensive Care Med (34(12), pp. 2273-8). United States.

Clinical Trials

Video & News